Показано 0 из 0
Дата |
---|
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.885
|
0.975
|
0.945
|
0.945
|
0.945
|
0.945
|
|
|
|
|
0.89
|
0.985
|
0.955
|
0.955
|
0.955
|
0.955
|
|
|
|
|
0.915
|
1.01
|
0.955
|
0.955
|
0.955
|
0.955
|
|
|
|
|
0.90
|
0.995
|
0.94
|
0.94
|
0.94
|
0.94
|
|
|
|
|
0.885
|
0.98
|
0.97
|
0.97
|
0.97
|
0.97
|
|
|
|
|
0.895
|
0.99
|
0.97
|
0.97
|
0.97
|
0.97
|
|
|
|
|
0.905
|
1.01
|
0.97
|
0.97
|
0.97
|
0.97
|
|
|
|
|
0.925
|
1.02
|
0.955
|
0.955
|
0.955
|
0.955
|
|
|
|
|
0.925
|
1.01
|
0.955
|
0.955
|
0.955
|
0.955
|
|
|
|
|
0.895
|
0.975
|
0.965
|
0.965
|
0.965
|
0.965
|
|
|
|
|
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.